Evidence map›Paper›PMID 15968073›Full record

ArticleJournal of bacteriology2005

Sialylation of group B streptococcal capsular polysaccharide is mediated by cpsK and is required for optimal capsule polymerization and expression.

D O Chaffin, L M Mentele, C E Rubens

Abstract readComparative Study
In one paragraph

Article in Journal of bacteriology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 71 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Antimicrobial Resistance and Virulence Genes ofJournal of veterinary research · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. AtxA-Controlled Small RNAs ofFrontiers in microbiology · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Status of group B streptococcal vaccine development.Clinical and experimental vaccine research · 2018
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

D O ChaffinDepartment of Pediatrics, Children's Hospital and Regional Medical Center, University of Washington, Seattle, WA 98109, USA.
L M Mentele
C E Rubens
Seattle Children's Hospital · USUniversity of Washington · US

Funding

GROUP B STREPTOCOCCAL VIRULENCE TYPE III POLYSACCHARIDER01AI022498 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI RUBENS, CRAIG E. · 1988 to 2003
$928k
GROUP B STREPTOCOCCAL VIRULENCE TYPE III POLYSACCHARIDER23AI022498 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI RUBENS, CRAIG E. · 1985 to 1987
–
NIAID NIH HHS AI 22498NIAID NIH HHS R01 AI022498
6 · The paper itself

Abstract

Several bacterial pathogens have evolved the means to escape immune detection by mimicking host cell surface carbohydrates that are crucial for self/non-self recognition. Sialic acid, a terminal residue on these carbohydrates, inhibits activation of the alternate pathway of complement by recruiting the immune modulating molecule factors H, I, and iC3b. Sialylation of capsular polysaccharide (CPS) is important for virulence of group B streptococci (GBS), a significant human pathogen. We previously reported that cpsK, a gene within the cps locus of type III GBS, could complement a sialyltransferase deficient lst mutant of Haemophilus ducreyi, implicating its role in sialylation of the GBS capsule. To explore the function of cpsK in GBS capsule production, we created a mutant in cpsK. Immunoblot analysis and enzyme-linked immunosorbent assay using anti-type III CPS antisera demonstrated that the mutant CPS did not contain sialic acid. This was confirmed by high-performance liquid chromatography after mild acid hydrolysis of the CPS. Although increased CPS chain length was seen for this strain, CPS production was <20% of the parental isolate. An episomal cpsK copy restored synthesis of sialo-CPS to wild-type levels. These data support our hypothesis that cpsK encodes the GBS CPS sialyltransferase and provide further evidence that lack of CPS oligosaccharide sialylation reduces the amount of CPS expressed on the cell surface. These observations also imply that one or more of the components involved in synthesis or transport of oligosaccharide repeating units requires a sialo-oligosaccharide for complete activity.

Indexed as

Bacterial CapsulesN-Acetylneuraminic AcidOperonPolysaccharides, BacterialSialyltransferasesStreptococcus agalactiaeVirulenceN-Acetylneuraminic AcidPolysaccharides, BacterialSialyltransferases

Identifiers

PMID15968073
PMCPMC1151781
OpenAlexW2129202145

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.